November, 2025
As of Q3 2025, the median transaction value in healthcare was $121 million. As of Q3 2025, strategic buyers accounted for 90% of transactions.
Select recent notable publicly announced M&A transactions:
– Roche Holding AG closed its acquisition of 89bio for $3.1 billion in September 2025.
– ArchiMed SAS closed its acquisition of ARK Diagnostics for $420 million in September 2025.
– MannKind Corporation closed its acquisition of scPharmaceuticals for $409 million in August 2025.
– CorMedix closed its acquisition of Melinta Therapeutics for $325 million in August 2025.
– Bachem Americas closed its acquisition of RapheGenerics for $2.3 billion in July 2025.
Securities offered through Peakstone Securities, LLC member FINRA/SIPC. All investments involve market risks, including the loss of principal. Past performance does not guarantee future results. Information on this website is not intended to be a recommendation or specific investment advice. Securities or companies mentioned are for illustrative purposes only and are not a recommendation to buy or sell. Investment decisions should be made based on an individual’s objectives and risk tolerance. Information on this website is intended for US residents only and does not constitute an offer to buy or sell securities in any jurisdiction to whom it is not lawful to make such an offer. Peakstone Securities, LLC is registered as a broker-dealer in the following states: Click here to see licensed states. The information provided does not constitute an offer to buy or sell in any jurisdiction to whom it is not lawful to make such an offer.
Download Report
